Latest News about MRK
Recent news which mentions MRK
From Benzinga
From Benzinga
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
July 23, 2024
From Benzinga
From Motley Fool
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
July 21, 2024
From Motley Fool
This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
July 21, 2024
From Motley Fool
Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits
July 18, 2024
From Benzinga
2 Magnificent Stocks to Buy With $500
July 18, 2024
From Motley Fool
From Benzinga
3 Top Cancer Treatment Stocks to Buy Now
July 17, 2024
From InvestorPlace
3 Biotech Stocks to Buy in Case of Another Pandemic
July 16, 2024
From InvestorPlace
Forget Nvidia: Billionaires Are Dumping It and Piling Into These 3 Surprising Value Stocks Instead
July 16, 2024
From Motley Fool
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
From Benzinga
Merck's Acquisition of EyeBio Finalized
July 12, 2024
From Benzinga
From Benzinga
3 Under-$10 Biotech Stocks That Could Make You Rich
July 11, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
3 Undervalued Blue-Chip Stocks Ready for a Big Comeback
July 09, 2024
From InvestorPlace
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
From Benzinga
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
July 05, 2024
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.